{"id":"50c02dc6-b605-4206-b59b-257bb6b7b197","kind":"news","code":"50c02dc6-b605-4206-b59b-257bb6b7b197","name":"iRegene completes equity financing","nameBasis":"translated-title","summary":"On 2026-03-30, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Beijiguang Venture Capital, Guanzi Venture Capital, Hehui Biotechnology.","description":"","country":null,"category":null,"originalName":"睿健医药完成股权投资融资","eventDate":"2026-03-30T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-18T17:28:17.323Z","englishUpdatedAt":"2026-10-20T18:21:37.366Z","reviewedAt":"2026-10-20T18:21:37.366Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"c409aa1ab95ed47d2370955a5939a9b2b09c7f5797684e75afc83cc49c055492","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"originalText":"2026年3月30日，据烯牛数据报道，睿健医药完成股权投资融资，金额未披露。投资方为北极光创投、关子创投、荷慧生物。","sources":[],"related":[{"id":"46912db4-929a-452f-85e6-bf2574fde0d5","kind":"institutions","code":"UB-I185","name":"Beijiguang Venture Capital","nameBasis":"transliterated","summary":"A well-known Chinese venture capital firm focused on early-stage technology and healthcare investments.","description":"A well-known Chinese venture capital firm focused on early-stage technology and healthcare investments.","country":null,"category":null,"originalName":"北极光创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.119Z","englishUpdatedAt":"2026-10-15T21:21:01.645Z","reviewedAt":"2026-10-15T21:21:01.645Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a8028420b266fdcda07a3c9671ee7ce3af8078ac855a0d85bbed40f24b8d52c1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/beijiguang-venture-capital"},{"id":"5daaedb2-f61b-444d-ae08-2b97d6c03972","kind":"institutions","code":"UB-I9200","name":"Guanzi Venture Capital","nameBasis":"transliterated","summary":"","description":"","country":null,"category":null,"originalName":"关子创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T15:46:30.928Z","englishUpdatedAt":"2026-10-15T17:35:39.086Z","reviewedAt":"2026-10-15T17:35:39.086Z","snapshotAt":"2026-10-15T16:06:35.585Z","sourceHash":"72b92026860c5e3173a92150733198053dc63644308c68872d9684bc2320215b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/guanzi-venture-capital"},{"id":"9956bb53-1167-444a-9c20-a4d9f069be4c","kind":"institutions","code":"UB-I9206","name":"Hehui Biotechnology","nameBasis":"transliterated","summary":"","description":"","country":null,"category":null,"originalName":"荷慧生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T15:46:31.226Z","englishUpdatedAt":"2026-10-15T17:35:39.461Z","reviewedAt":"2026-10-15T17:35:39.461Z","snapshotAt":"2026-10-15T16:06:35.585Z","sourceHash":"d43acd2a3174819da70f21d8f3e7e118b1fe52339d21dea4e570c866dac9b92b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hehui-biotechnology"},{"id":"c6f40f74-5248-4720-8404-fd1e03022e90","kind":"companies","code":"UB-C5987","name":"iRegene","nameBasis":"source-english","summary":"AI and chemically induced cell drug research and development.","description":"","country":"China","category":null,"originalName":"睿健医药","eventDate":null,"website":"https://www.iregene.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:36.154Z","reviewedAt":"2026-10-20T18:26:36.154Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"4f1558709e5410f70940856de858bdad558b4dea9749771117809729b847f483","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C5987"}],"path":"/news/50c02dc6-b605-4206-b59b-257bb6b7b197","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"iRegene","path":"/companies/UB-C5987"}},"canonical":"https://uniquebase.ai/news/50c02dc6-b605-4206-b59b-257bb6b7b197"}